Morgan Stanley’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.65M | Sell |
|
|||||
|
2024
Q3 | $1.54M | Buy |
|
|||||
|
2024
Q2 | $1.06M | Sell |
|
|||||
|
2024
Q1 | $1.49M | Sell |
|
|||||
|
2023
Q4 | $2.3M | Buy |
|
|||||
|
2023
Q3 | $664K | Sell |
|
|||||
|
2023
Q2 | $978K | Buy |
|
|||||
|
2023
Q1 | $1.48M | Buy |
|
|||||
|
2022
Q4 | $562K | Buy |
|
|||||
|
2022
Q3 | $245K | Sell |
|
|||||
|
2022
Q2 | $188K | Buy |
|
|||||
|
2022
Q1 | $236K | Buy |
|
|||||
|
2021
Q4 | $306K | Buy |
|
|||||
|
2021
Q3 | $254K | Buy |
|
|||||
|
2021
Q2 | $212K | Buy |
|
|||||
|
2021
Q1 | $6K | Sell |
|
|||||
|
2020
Q4 | $109K | Buy |
|
|||||
|
2020
Q3 | $18K | Buy |
|